Swainson R, SenGupta D, Shetty T, Watkins L H A, Summers B A, Sahakian B J, Polkey C E, Barker R A, Robbins T W
Department of Experimental Psychology, University of Cambridge, Cambridge, UK.
Neuropsychologia. 2006;44(8):1290-304. doi: 10.1016/j.neuropsychologia.2006.01.028. Epub 2006 Mar 10.
It has been suggested that Parkinson's disease (PD) impairs the ability to learn on the basis of reward or reinforcing feedback i.e., by trial-and-error. In many learning tasks, particular 'dimensions' of stimulus information are relevant whilst others are irrelevant; therefore, efficient performance depends on identifying the dimensions of these 'compound' stimuli and selecting the relevant dimension for further processing. We investigated the ability of patients with PD, as well as patients with Huntington's disease and patients with frontal or temporal lobe lesions, to learn visual discriminations which required either a number of associations to be learned concurrently (the 'eight-pair' task) or the selection of information from compound stimuli (the 'five-dimension' task), both tasks being learned by trial-and-error. None of the basal ganglia disorder patient groups was impaired on the eight-pair task, militating against a crucial role for these brain structures in trial-and-error learning per se. Patients with mild, medicated PD, but not unmedicated PD patients, were impaired at identifying all five feature dimensions in the five-dimension task, implying dopaminergic 'overdosing' of the ability to analyse compound stimuli in terms of their component dimensions. Temporal lobe lesion patients performed similarly, suggesting that the temporal lobe may be the site of the medication overdose effect. Patients with severe, medicated PD were impaired at compound discrimination learning on the five-dimension task in the absence of an underlying impairment in identifying component stimulus dimensions; this pattern resembled that seen in Huntington's disease and frontal lobe lesion patients, implying that fronto-striatal circuitry is involved in the formation of rules based upon selected stimulus dimensions.
有人提出,帕金森病(PD)会损害基于奖励或强化反馈(即通过试错)进行学习的能力。在许多学习任务中,刺激信息的特定“维度”是相关的,而其他维度则不相关;因此,高效的表现取决于识别这些“复合”刺激的维度,并选择相关维度进行进一步处理。我们研究了帕金森病患者、亨廷顿病患者以及额叶或颞叶病变患者学习视觉辨别能力,这些辨别任务要么需要同时学习多个关联(“八对”任务),要么需要从复合刺激中选择信息(“五维度”任务),这两个任务均通过试错来学习。没有一个基底神经节疾病患者组在“八对”任务中受损,这表明这些脑结构在试错学习本身中不起关键作用。轻度、正在服药的帕金森病患者在“五维度”任务中识别所有五个特征维度时受损,但未服药的帕金森病患者则未受损,这意味着多巴胺能对根据复合刺激的组成维度分析复合刺激的能力“用药过量”。颞叶病变患者表现类似,表明颞叶可能是药物过量效应的发生部位。重度、正在服药的帕金森病患者在“五维度”任务中的复合辨别学习受损,而在识别组成刺激维度方面没有潜在损伤;这种模式与亨廷顿病和额叶病变患者相似,这意味着额纹状体回路参与基于所选刺激维度形成规则。